Michelle M. Lebeau to Female
This is a "connection" page, showing publications Michelle M. Lebeau has written about Female.
Connection Strength
0.117
-
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer. 2016 Jan 15; 122(2):304-11.
Score: 0.027
-
Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms. Blood. 2015 Dec 24; 126(26):2899-901.
Score: 0.027
-
Overexpression and knockout of miR-126 both promote leukemogenesis. Blood. 2015 Oct 22; 126(17):2005-15.
Score: 0.026
-
Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL). Leuk Lymphoma. 2017 04; 58(4):950-958.
Score: 0.007
-
Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes. Proc Natl Acad Sci U S A. 2015 Nov 17; 112(46):E6359-68.
Score: 0.007
-
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014 Aug 14; 512(7513):198-202.
Score: 0.006
-
Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet. 2000 May 22; 9(9):1425-32.
Score: 0.002
-
Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group. Leukemia. 2000 Jan; 14(1):216-8.
Score: 0.002
-
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997 Mar 15; 89(6):2079-88.
Score: 0.002
-
Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes. 1994 Mar; 43(3):389-95.
Score: 0.001
-
Acute myeloid leukaemia in a patient with Seckel syndrome. J Med Genet. 1994 Feb; 31(2):148-9.
Score: 0.001
-
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood. 1993 Nov 15; 82(10):2975-84.
Score: 0.001
-
Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia. Leukemia. 1993 Nov; 7(11):1865-74.
Score: 0.001
-
Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood. 1993 May 15; 81(10):2728-34.
Score: 0.001
-
Molecular analysis of a t(11;14)(q23;q11) from a patient with null-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 1993 May; 7(1):38-46.
Score: 0.001
-
Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood. 1993 Feb 15; 81(4):883-8.
Score: 0.001
-
Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci U S A. 1991 Dec 01; 88(23):10735-9.
Score: 0.001